US2003108558A1PendingUtilityA1

Use of proteins as agents against autoimmune diseases

Assignee: ZETESIS SPAPriority: Sep 18, 1996Filed: Sep 3, 2002Published: Jun 12, 2003
Est. expirySep 18, 2016(expired)· nominal 20-yr term from priority
A61P 37/06A61P 37/00A61P 37/02A61P 3/10A61P 19/02A61K 38/00C07K 14/47C07K 14/4703Y10S530/846A61K 38/17
43
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The use of proteins extracted with perchloric acid from animal organs, for the preparation of medicaments active against autoimmune diseases, in particular with activity against atheroscelerosis, arthritis, multiple sclerosis, and diabetes.

Claims

exact text as granted — not AI-modified
1 . A method of treatment for autoimmune diseases, comprising administering to an animal in need of such treatment a treatment effective amount of proteins extracted with perchloric acid from mammal liver.  
     
     
         2 . The method according to  claim 1 , wherein the treatment is for atherosclerosis following a transplant.  
     
     
         3 . The method of treatment for atherosclerosis of  claim 2 , comprising administering to an animal in need of such treatment a treatment-effective amount of the protein of SEQ ID NO:1.  
     
     
         4 . The method according to  claim 1 , wherein the treatment is for arthritis.  
     
     
         5 . The method of treatment for arthritis of  claim 4 , comprising administering to an animal in need of such treatment a treatment-effective amount of the protein of SEQ ID NO:1.  
     
     
         6 . The method according to  claim 1 , wherein the treatment is for multiple sclerosis.  
     
     
         7 . The method of treatment for multiple sclerosis of  claim 6 , comprising administering to an animal in need of such treatment a treatment-effective amount of the protein of SEQ ID NO:1.

Join the waitlist — get patent alerts

Track US2003108558A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.